Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning Balances at Dec. 31, 2022     $ 1 $ 50,020 $ (44,556) $ 5,465
Beginning Balances (in shares) at Dec. 31, 2022     1,051,098      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share issuance, net       300   300
Share issuance, net (in shares)     50,000      
Stock-based compensation       (10)   (10)
Net Income (Loss)         (3,144) (3,144)
Ending Balance at Mar. 31, 2023     $ 1 50,310 (47,700) 2,611
Ending Balance (in shares) at Mar. 31, 2023     1,101,098      
Beginning Balances at Dec. 31, 2023     $ 7 55,292 (70,634) (15,335)
Beginning Balances (in shares) at Dec. 31, 2023     6,720,460      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation       174   $ 174
Stock-based compensation (in shares)     268,758     268,758
Net Income (Loss)         (3,761) $ (3,761)
Convertible debt converted into common shares     $ 1 333   334
Convertible debt converted into common shares (in shares)     1,337,371      
Ending Balance at Mar. 31, 2024 $ (22) $ (22) $ 8 $ 55,799 $ (74,417) $ (18,610)
Ending Balance (in shares) at Mar. 31, 2024     8,326,589